ASCO Genitourinary Symposium 2024: Late‑Breaking Presentations on EV‑302 and AMBASSADOR

Medical News Podcast

English - May 16, 2024 23:00 - 10 minutes - 6.07 MB - ★★★★★ - 17 ratings
Science medicine medical clinician clinical healthcare peerdirect pvroundup health disease disorders Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Specialist Spotlight: Advanced Urothelial Carcinoma: Considerations in Therapeutic Sequencing

Next Episode: Specialist Spotlight: Urothelial Carcinoma Update From the ASCO GU Symposium 2024

Drs. Jonathan Rosenberg and Alicia Morgans share their insights into some late-breaker abstracts presented at the 2024 ASCO GU symposium in San Francisco. The first is a subgroup analysis from EV‑302 with enfortumab vedotin and pembrolizumab, and the other is AMBASSADOR, which looks at adjuvant pembrolizumab in locally advanced and muscle invasive urothelial cancer.